In the study by Martinez-Trillos et al. the authors found that TLR/MYD88-mutated CLL was seen in a group of young patients with advanced stage at presentation, associated with mutated IGHV, with less ZAP-70 and CD38 expressions and a better OS23. This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.